Department of Oncology Medicine, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
The Key Laboratory of Biomarker High Throughput Screening and Target Translation of Breast and Gastrointestinal Tumor, Dalian, China.
J Int Med Res. 2024 Jan;52(1):3000605231220890. doi: 10.1177/03000605231220890.
CBP/p300 interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 (CITED1) is a transcriptional activator belonging to the non-DNA-binding transcription co-regulator family. It regulates diverse pathways, including the transforming growth factor/bone morphogenetic protein/SMAD, estrogen, Wnt-β-catenin, and androgen-AR signaling pathways, by binding to CBP/p300 co-activators through its conserved transactivation domain CR2. CITED1 plays an important role in embryonic development and a certain regulatory role in the occurrence and development of various tumors. In this article, the biological characteristics, expression regulation, participating signaling pathways, and potential roles of CITED1 in the clinical diagnosis and treatment of tumors are reviewed.
CBP/p300 相互作用转录激活因子与富含谷氨酸/天冬氨酸的羧基末端域 1(CITED1)是一种转录激活因子,属于非 DNA 结合转录共激活因子家族。它通过其保守的转录激活结构域 CR2 与 CBP/p300 共激活因子结合,调节多种途径,包括转化生长因子/骨形态发生蛋白/SMAD、雌激素、Wnt-β-连环蛋白和雄激素-AR 信号通路。CITED1 在胚胎发育中发挥重要作用,并在各种肿瘤的发生和发展中具有一定的调节作用。本文综述了 CITED1 的生物学特性、表达调控、参与的信号通路以及在肿瘤临床诊断和治疗中的潜在作用。